Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 308 Lung Neoplasms 70 Neoplasms 50 Neoplasm Metastasis 33 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Colorectal Neoplasms 20 Carcinoma 20 Mesothelioma 15 Breast Neoplasms 15 Mesothelioma, Malignant 13 Small Cell Lung Carcinoma 11 Melanoma 10 Adenocarcinoma 10 Neoplasms by Site 9 Adenocarcinoma of Lung 8 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Lung Diseases 7 Thoracic Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Non-Squamous Non-Small Cell Lung Cancer 6 Uterine Cervical Neoplasms 5 Respiratory Tract Neoplasms 5 Respiratory Tract Diseases 5 Recurrence 5 Rectal Neoplasms 5 Neoplasms by Histologic Type 5 NSCLC 5 Head and Neck Neoplasms 5 Endometrial Neoplasms 5

Interventions

Docetaxel 4 pembrolizumab 2 Carboplatin 2 tislelizumab 1 nazartinib 1 lenvatinib 1 cemiplimab 1 aflutinib 1 abivertinib 1 Rosuvastatin Calcium 1 Platinum Compounds 1 Pemetrexed 1 Nivolumab 1 Midazolam 1 Gefitinib 1 Food 1 Esomeprazole 1 Dabigatran 1 Cisplatin 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Non-small Cell Lung Cancer × Pemetrexed × Clear all

NCT06452277 2026-05-18

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡